Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 309,338
  • Shares Outstanding, K 20,205
  • Annual Sales, $ 79,180 K
  • Annual Income, $ -64,720 K
  • EBIT $ -67 M
  • EBITDA $ -59 M
  • 60-Month Beta 1.19
  • Price/Sales 3.82
  • Price/Cash Flow 10.04
  • Price/Book 2.16

Options Overview Details

View History
  • Implied Volatility 61.20% (-1.44%)
  • Historical Volatility 41.36%
  • IV Percentile 18%
  • IV Rank 22.71%
  • IV High 149.14% on 01/30/26
  • IV Low 35.35% on 01/22/26
  • Expected Move (DTE 23) 0.78 (5.11%)
  • Put/Call Vol Ratio 0.54
  • Today's Volume 20
  • Volume Avg (30-Day) 218
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 1,094
  • Open Int (30-Day) 3,369
  • Expected Range 14.53 to 16.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 05/31/26
See More
  • Average Estimate $0.28
  • Number of Estimates 2
  • High Estimate $0.29
  • Low Estimate $0.27
  • Prior Year $0.45
  • Growth Rate Est. (year over year) -37.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.09 +38.05%
on 03/30/26
15.56 -1.58%
on 04/10/26
+3.64 (+31.19%)
since 03/20/26
3-Month
11.09 +38.05%
on 03/30/26
21.01 -27.13%
on 01/23/26
-5.12 (-25.06%)
since 01/21/26
52-Week
11.09 +38.05%
on 03/30/26
36.45 -58.00%
on 04/24/25
-18.59 (-54.84%)
since 04/21/25

Most Recent Stories

More News
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products

Mechanistic modeling approach and experimental integration designed to improve early risk identification, strengthen regulatory confidence, and expand AI-enabled workflows connecting data to decision-making...

SLP : 15.31 (+2.27%)
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School

More than 1,400 participants across 65+ countries underscores accelerating adoption of model-informed workflows and growing demand for applied modeling expertise

SLP : 15.31 (+2.27%)
Simulations Plus: Fiscal Q2 Earnings Snapshot

Simulations Plus: Fiscal Q2 Earnings Snapshot

SLP : 15.31 (+2.27%)
Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results

Revenue grew 8% with increases in both software and services

SLP : 15.31 (+2.27%)
Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date

Conference call to be on Thursday, April 9, 2026, at 5 p.m. ET

SLP : 15.31 (+2.27%)
Simulations Plus Announces Strategic Collaboration Programs for AI-Enabled Modeling

Co-development initiatives to advance next-generation workflows, accelerate adoption, and expand the role of AI within model-informed drug development

SLP : 15.31 (+2.27%)
Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD

Expert panel at the 2026 ASCPT Annual Meeting brings together leaders with industry and regulatory experience to explore practical, accountable AI implementation

SLP : 15.31 (+2.27%)
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations

Extended projects support ongoing research into computational approaches and new approach methodologies for food and chemical safety assessment

SLP : 15.31 (+2.27%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Feb. 8, 2026 /PRNewswire/ --

SLP : 15.31 (+2.27%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Feb. 3, 2026 /PRNewswire/ --

SLP : 15.31 (+2.27%)

Business Summary

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab,...

See More

Key Turning Points

3rd Resistance Point 15.90
2nd Resistance Point 15.63
1st Resistance Point 15.47
Last Price 15.31
1st Support Level 15.03
2nd Support Level 14.76
3rd Support Level 14.60

See More

52-Week High 36.45
Fibonacci 61.8% 26.76
Fibonacci 50% 23.77
Fibonacci 38.2% 20.78
Last Price 15.31
52-Week Low 11.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.